Neotract

Neotract

Verified
Developing minimally invasive and clinically effective devices that address unmet needs in the field of urology, current focus on the UroLift system.

Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$51—77m (Dealroom.co estimates Jan 2017.)
Mountain View California (HQ)